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There is increasing evidence of activity-related plasticity
in auditory pathways. The present study examined the
effects of decreased activity on immunolocalization of
the inhibitory neurotransmitter glycine in the cochlear
nucleus of the rat after bilateral cochlear ablation. Spe-
cifically, glycine-immunoreactive puncta adjacent to
somatic profiles were compared in normal hearing ani-
mals and animals deafened for 14 days. The number of
glycine-immunoreactive puncta surrounding somatic
profiles of spherical and globular bushy cells, glycine-
immunoreactive type I stellate multipolar cells, radiate
neurons (type II stellate multipolar cells), and fusiform
cells decreased significantly. In addition, the number of
glycine immunopositive tuberculoventral (vertical or
corn) cells in the deep layer of the dorsal cochlear
nucleus also decreased significantly. These results sug-
gest that decreased inhibition reported in cochlear
nucleus after deafness may be due to decreases in
glycine. VC 2005 Wiley-Liss, Inc.
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There is increasing evidence of plasticity in the
mature auditory system, with decreased activity from
deafness or increased activity from noise overstimulation
capable of inducing marked changes (recently reviewed
by Syka, 2002). Activity-induced changes in the auditory
brain stem range from changes in gene expression (e.g.,
Holt et al., 2005) to changes in neuronal response profiles
(Francis and Manis, 2000). One of the most striking deaf-
ness-related changes in the auditory brain stem is a
decrease in inhibition and an increase in spontaneous or
evoked excitation, found in both the inferior colliculus
(IC) and the cochlear nucleus (CN; Gerken, 1979;
Willott and Lu, 1982; Bledsoe et al., 1995; Kaltenbach,
2000; Mossop et al., 2000; Salvi et al., 2000; Willott and
Turner, 2000; Shaddock Palombi et al., 2001), often lead-
ing to a change in the tonotopic map (Leake et al., 2000;
Nagase et al., 2000; Snyder et al., 2000). In the IC, the
decreased inhibition seems associated with decreases in
the inhibitory amino acid neurotransmitter g-aminobuty-
ric acid (GABA), with studies showing decreased GABA
release (Bledsoe et al., 1995) and decreases in the GABA-
synthesizing enzyme glutamic acid decarboxylase (GAD)
as well as GABA binding (Bauer et al., 2000; Milbrandt
et al., 2000; Mossop et al., 2000; Caspary et al., 2002). In
the CN, however, many studies suggest that glycine is the
major inhibitory transmitter (Altschuler et al., 1986; Wu
and Oertel, 1986; Caspary et al., 1987, 1994; Wenthold
et al., 1987; Adams and Mugnaini, 1990; Bledsoe et al.,
1990; Wickesberg and Oertel, 1990; Helfert et al., 1992;
Kolston et al., 1992; Kuwabara and Zook, 1992, 1999;
Grothe and Sanes, 1993; Wickesberg et al., 1994; Wu
and Kelly, 1994; Sato et al., 1995; Golding and Oertel,
1996; Juiz et al., 1996; Harty and Manis, 1998; Doucet
et al., 1999; Godfrey et al., 2000; Zheng et al., 2000).
Decreases in glycine-immunoreactive neurons and puncta
(Willott et al., 1993; Willott and Turner, 2000) and
changes in glycine receptor subunits (Krenning et al.,
1998) are associated with age-related hearing loss. Glycine
release, glycine uptake, and glycine receptor binding all
change after cochlear ablation (Suneja et al., 1998a,b;
Potashner et al., 2000). Because glycine is implicated in
deafness-related decreases in inhibition within the CN,
then decreased glycine levels might also be expected in
the CN. We therefore addressed whether there are deaf-
ness-related decreases in glycine immunoreactivity within
the cochlear nucleus 14 days after deafness. The 14-day
point after deafness was chosen because marked decreases
in the release of GABA have been observed in the
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inferior colliculus at this time after deafness (Bledsoe
et al., 1995, 1997).
MATERIALS AND METHODS
Animals and Surgical procedures
All animals used in this study were female Sprague-
Dawley rats weighing between 200–300 g and were obtained
from Charles River Laboratories. The experimental group of
rats was bilaterally deafened via introduction of neomycin
through each round window. This deafened group (n ¼ 5)
was assessed 14 days after deafening. The animals in the con-
trol group (n ¼ 5) were age matched and had normal hearing
based on auditory brain stem response (ABR) measures. Each
rat in the deafened group was anesthetized with intramuscular
injections of xylazine (8 mg/kg) and ketamine (75 mg/kg).
Local injections of 1% lidocaine-HCl solution were also made
at the site of each surgical incision (subcutaneous). Surgical
procedures were carried out under aseptic conditions. The
skin incision was made through the postauricular region of
the lateral neck. The bulla was exposed without resection of
any major muscles. A small defect in the bulla was opened
and 30 ml of 30% neomycin were injected over 3 min
through the round window using a Hamilton syringe. The
skin incision was then closed with sutures. After surgery, ani-
mal were injected with sterile 0.9% sodium chloride solution
and allowed to recover under a heating lamp.
Hearing Loss Assessment
Hearing was assessed by auditory brain stem response
(ABR) measures at 2, 10, and 20 kHz in all animals at the
beginning of the study and only those with normal hearing
were included in the study. A second measure of hearing was
done 14 days after the deafening, for animals in the deafness
group. An 80-dB shift from the normal control threshold
averaged across the three frequencies was considered necessary
for continued inclusion in the deafness group.
Tissue Processing
All rats were deeply anesthetized with a single intraperi-
toneal dose of 350 mg/kg of chloral hydrate and then perfused
transcardially with 30 ml of 0.12 M phosphate buffered saline
(PBS; pH 7.4), followed immediately by 300 ml mixed alde-
hyde fixative containing 2% paraformaldehyde and 1.25% glu-
taraldehyde in 0.12 M phosphate buffer. Animals were decapi-
tated and brains were carefully removed from the cranium
and then immersed in the same fixative for 90 min at 48C for
post fixation. After an 8–14-hr rinse in PBS, the lower brain
stem (medulla and pons) was dissected and glued onto a
chuck. Coronal sections (150 mm) containing the CN were
cut with a vibrating microtome (Vibratome). Slices were
chosen that contained a predefined (based on anatomic land-
marks and cytoarchitectural features), consistent, region of
interest (ROI) in the anteroventral cochlear nucleus (AVCN),
posteroventral cochlear nucleus (PVCN), or the dorsal coch-
lear nucleus (DCN). These sections were placed in 1% OsO4
in phosphate buffer for 45 min. This was followed by a rinse
in phosphate buffer, incubation for 1 hr in 2% uranyl acetate,
and another phosphate buffer rinse. Sections were then dehy-
drated through a graded series of ethanol and then infiltrated
through graded mixtures of EPON 812 and propylene oxide.
After 4 hr in 100% EPON 812, sections were placed between
plastic sheets and polymerized for 48 hr at 608C. Sections
were viewed under a Leica dissecting microscope. For each
animal assessed, an area containing the ROIs (AVCN, PVCN,
and DCN) was cut out of the specific sections in which they
were present and glued onto an ultramicrotome chuck. Serial
1-mm semithin sections were then cut through the ROI on a
Reichert ultramicrotome. Systematic random sampling
(Coggeshall and Lekan, 1996) was utilized, where the starting
point for a series were random with the next sections in the
series and then assessed at fixed intervals. Five 1-mm sections
(separated by 12 mm; the 1st, 13th, 25th, 37th, and 49th in
each series once the start point was selected) from each rat
were processed for immunocytochemistry and quantitative
analysis. Five adjacent 1-mm sections (the 2nd, 14th, 26th,
39th and 50th in the series) received a Nissl stain (toluidine
blue) for anatomic reference.
Immunocytochemistry
Sections were etched for 40 min in sodium ethoxide,
rehydrated, and then treated in 1% sodium periodate for
10 min. Postembedding immunocytochemistry was then car-
ried out. Sections were incubated 48C for 40 hr in rabbit
anti-glycine antibody IgG (Chemicon, Temecula, CA) diluted
1:1,200 in 0.5 M Tris buffer containing 5.0% normal goat
serum. After thorough rinsing in Tris buffer, sequential incu-
bations were carried out after using the Vectastain procedure
(biotinylated goat anti-rabbit IgG diluted 1:100 in 0.5 M Tris
buffer containing 5.0% normal goat serum; avidin-biotin-per-
oxidase complex [ABC Kit], diluted in 0.5 M Tris buffer).
Sections were then treated for 3 min in 0.05% diaminobenzi-
dine (DAB) in 0.01% H2O2 to visualize the reaction product.
The DAB reaction was then stopped rapidly by rinsing several
times with double-distilled water. Sections were then dried,
dehydrated, and coverslipped.
Image Acquisition
Five sections each from five rats in each group were used
for AVCN, PVCN, and DCN assessments. Digital images were
acquired with a Spot camera (Diagnostic Instruments, Inc.) on
a Zeiss Axioscop2 photomicroscope and assessed quantitatively
using MetaMorph (Universal Imaging) software. A grayscale
image from each ROI on a section was acquired using the
CCD camera while holding all image-gathering parameters
constant. Cells types were differentiated based on the size,
shape, and location criteria of Cant and Morest (Cant and Morest,
1979a,b; Cant, 1981) as well as glycine-immunoreactive stain-
ing. A somatic profile of a neuron needed to contain a nucleus
to be assessed. Because nuclei are no larger than the 12-mm
interval between sections, this ensured that the same neuron
would be not assessed twice. Every neuron with an identifiable
nucleus was assessed within each predefined ROI. The somatic
profile of each neuron with a nucleus was circled and the area,
perimeter, and shape of the neurons were entered automatically
into a spreadsheet program. Positive immunostaining was
defined as intensity at least 7 over background and positive
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puncta were defined further by size constraints (1.0–4.5 mm2)
and shape (round to oval) criteria. The number of glycine-
immunoreactive puncta directly apposing each circled somatic
profile was then determined and entered into the spreadsheet
program. Additionally, the number of immunopositive tuber-
culoventral cells within the deep layer of the DCN was also
determined in DCN sections.
Statistical Analyses
Analysis of variance (ANOVA) was carried out using
StatView software. Comparison between normal hearing and
deafened groups was made for axosomatic puncta and for the
cell area for each cell type from each of 25 sections assessed in
each group. The average was calculated per animal, with
degrees of freedom (df) equal to 1 in the numerator (deaf vs.
normal) and 8 in the denominator (five animals per group) with
a confidence level of 95% necessary for significance. A Scheffe
multiple comparison test was used for post-hoc comparisons.
RESULTS
Glycine Immunoreactivity: Normal
Glycine-immunoreactive staining in the CN of
normal hearing rats (Fig. 1 and 2) was consistent with
the results of previous studies (Altschuler et al., 1986;
Wenthold, 1987; Wenthold et al., 1987; Wickesberg
and Oertel, 1990; Kolston et al., 1992; Wickesberg
et al., 1994; Juiz et al., 1996; Doucet et al., 1999). Most
neurons in the VCN were not immunostained for gly-
cine; however, glycine-immunoreactive radiate neurons
(type II stellate multipolar cells; Doucet and Ryugo,
1997; Doucet et al., 1999) and smaller glycine-immu-
noreactive type I stellate multipolar cells were found
throughout the magnocellular area of the VCN. Almost
all neurons in the magnocellular region of the VCN had
glycine-immunoreactive puncta on their somata. These
ranged from few on the soma of type I stellate multipo-
lar cells to numerous on the soma of spherical and glob-
ular bushy cells. In the DCN (Fig. 1), many glycine-
immunostained cells were found in the molecular layer
and glycine-immunostained tuberculoventral (vertical,
corn) cells (Wickesberg et al., 1991, 1994) were in the
deep layer. Numerous glycine-immunoreactive axoso-
matic puncta were found on fusiform cells of the fusi-
form layer.
Deafness-Related Changes in CN
Because there was also a decrease in the area of
somatic profiles for most CN cell types after deafness, an
increase in the density of glycine-immunostained axoso-
matic puncta could theoretically result as the area they
could contact shrinks, with an ‘‘artificial’’ increase in
their number per somatic profile. The present study,
however, found marked decreases after deafening in the
Fig. 1. Glycine immunoreactivity in the dorsal cochlear nucleus
(DCN). The molecular, fusiform and deep layers of the DCN contain
many glycine-immunolabeled puncta. As expected, the cartwheel cells
in the molecular layer are glycine immunopositive. The fusiform neu-
rons in the fusiform layer are immunonegative for glycine. Mol, molec-
ular layer; Fus, fusiform layer; Deep, deep layer. Scale bar ¼ 25 mm.
Fig. 2. Glycine immunoreactivity in the ventral cochlear nucleus in
normal hearing rats (A–C) and in rats 14 days after bilateral deafening
(D, E). Glycine immunolabeling decreases in intensity and in the
number of axosomatic puncta on most cell types 14 days after deaf-
ness. Scale bar ¼ 5 mm.
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number of glycine-immunostained axosomatic puncta
considered either as the total per somatic profile or the
number per 10 mm of somatic profile. Whatever effect
the change in cell size might have had was overcome by
the magnitude of the decrease in labeled puncta. There
was also a decrease in the number of glycine-immunostained
tuberculoventral cells in the deep layer of the DCN.
Spherical bushy cells. Spherical bushy cells (nor-
mal, n ¼ 145; deaf, n ¼ 199) were located in the AVCN
and were not immunostained for glycine. They were
spherical in shape, large (>250 mm2), and received large
numbers (>20) of glycine-immunopositive axosomatic
puncta on a somatic profile. The number of axosomatic
glycine-immunoreactive puncta per somatic profile for
spherical bushy cells was 39.5 6 4.9 in normal hearing
animals. In animals that were deaf for 14 days, there was a
significant (P  0.01) 59% decrease to 12.1 6 5.0 (Fig. 2
and 3). The decrease was 53% (significant, P  0.01)
when expressed as the number of puncta per 10 mm of
somatic profile, going from 13.0 6 2.2 in normal hearing
animals to 6.2 6 2.6 after deafening (Fig. 3).
Spherical bushy cells had an average area of
347.9 6 66.9 mm2 in the AVCN of normal hearing ani-
mals. Fourteen days after deafness there was a significant
(P  0.01) 21% decrease in average area to 274.3 6
67.9 mm2 (Fig. 4), comparable to what has been
described previously (Pasic and Rubel, 1989, 1991; Pasic
et al., 1994; Lesperance et al., 1995; Winsky and Jacobo-
witz, 1995; Nishiyama et al., 2000).
Globular bushy cells. Globular bushy cells were
located in the PVCN (Fig. 2A,B) and were not immu-
nostained for glycine (normal, n ¼ 165; deaf, n ¼ 235).
They were spherical in shape, large (>250 mm2) and
received large numbers (>20) of glycine-immunoposi-
tive axosomatic puncta on a somatic profile. The num-
ber of axosomatic glycine-immunoreactive puncta per
Fig. 3. Differences in the number of glycine-immunoreactive axoso-
matic puncta on different cell types in the cochlear nucleus (CN)
between normal hearing rats (white bars) and rats 14 days after bilat-
eral deafening (black bars). Data are expressed as the number of
labeled puncta on a somatic profile (top) and as the number of
puncta per 10 mm of somatic profile (bottom). Significant (*P 
0.05) decreases are seen for glycine-immunoreactive type I stellate
multipolar cells in posteroventral CN (PVCN), spherical bushy cells,
globular bushy cells, radiate cells (type II stellate multipolar cells) and
fusiform cells, but not glycine-immunoreactive type I stellate multi-
polar cells in anteroventral CN (AVCN). Error bars represent 61
standard deviation.
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somatic profile for globular bushy cells was 28.2 6 6.5
in normal hearing animals. In animals that were deaf for
14 days, there was a significant (P  0.01) 55% decrease
to 12.8 6 5.5 (Fig. 2B and 3). When expressed as the
number of puncta per 10 mm of somatic profile, there
was a significant (P  0.01) 49% decrease from 11.4 6
2.6 to 5.9 6 2.5.
Globular bushy cells in PVCN showed a significant
(P  0.01) decrease from an average area of 424.5 6
144.8 mm2 in the CN of normal hearing animals to an
average area of 346.3 6 104.1 mm2 14 days after deaf-
ness (Fig. 2 and 4).
Radiate cells (type II stellate multipolar
cells). Radiate cells were found in the AVCN and
PVCN (Fig. 2D,E) and were glycine immunopositive
(normal, n ¼ 4; deaf, n ¼ 4). They were spherical in
shape, large (>350 mm2), and received large numbers
(>20) of immunopositive axosomatic puncta per somatic
profile. The number of axosomatic glycine-immunoreac-
tive puncta per somatic profile for radiate cells was
18.5 6 1.7 in normal hearing animals, whereas in animals
that were deaf for 14 days, there was a significant (P 
0.01) 61% decrease to 7.3 6 3.2 (Fig. 2 and 3). When
expressed as the number of puncta per 10 mm of somatic
profile, there was the same significant (P  0.01) 61%
decrease, now from 6.4 6 1.8 to 2.5 6 1.0. Radiate cells
had an average area of 624.1 6 233.2 mm2 in the CN of
normal hearing animals and did not show significant
decrease in area after deafening (593.8 6 127.1 mm2;
Fig. 2D,E and 4).
Glycine-immunoreactive type I stellate multi-
polar cells. Glycine-immunoreactive type I stellate mul-
tipolar cells (Fig. 2C,E) were assessed in both the AVCN
(normal, n ¼ 72; deaf, n ¼ 47), and PVCN (normal, n ¼
97; deaf, n ¼ 117). They were small in size (<150 mm2)
and received few (<5) immunopositive puncta. In the
AVCN, there was not a significant deafness-related
decrease in the number of axosomatic glycine-immuno-
reactive puncta per somatic profile 14 days after deafen-
ing. There were 1.8 6 1.9 in normal hearing animals and
1.7 6 1.4 at 14 days after deafening. In PVCN, however,
these cells exhibited a 45% decrease from 2.2 6 2.2 in
normal hearing animals to 1.2 6 1.5 14 days after deafen-
ing (P  0.01; (Fig. 2 and 3). Results were similar, when
considered as the number of puncta per 10 mm of somatic
profile, staying at 1.6 in AVCN and decreasing 34% in
PVCN (P  0.01) from 1.8 6 1.8 to 1.2 6 1.7.
Glycine-immunoreactive type I stellate multipolar
cells had an average area of 89.6 6 26.0 mm2 in the
AVCN of normal hearing animals. Fourteen days after
deafness, there was a significant (P  0.05) decrease to an
average area of 78.9 6 26.6 mm2. In the PVCN, these
cells in were slightly larger 98.1 6 90.2 mm2 and their
decrease after 14 days of deafness to 69.8 6 20.3 mm2 was
significant (P  0.01; Fig. 4).
Fusiform cells. Fusiform cells in the fusiform layer
of the DCN (Fig. 1) were large (>250 mm2), fusiform
shaped, and were not immunostained for glycine (normal,
n ¼ 71; deaf, n ¼ 93). The number of axosomatic gly-
cine-immunoreactive puncta per somatic profile for fusi-
form cells was 23.6 6 5.7 in normal hearing animals.
After 14 days of deafness, there was a significant (P 
0.01) 60% decrease to 9.3 6 4.9 (Fig. 3). When expressed
as the number of puncta per 10 mm of somatic profile, there
was a significant (P  0.01) 45% decrease from 7.8 6 5.2
in normal hearing animals to 4.3 6 3.2 in animals 14 days
after deafening.
Fusiform cells of the DCN did not show a signifi-
cant deafness-related change in cell size, with an area of
390.8 6 132.0 mm2 in normal hearing animals and
406.5 6 132.8 mm2 in animals 14 days after deafening
(Fig. 4).
Tuberculoventral cells (vertical cells and corn
cells). Tuberuculoventral cells were small in size, gly-
cine immunopositive, and in the deep layer of the
DCN. The number of glycine immunopositive tubercu-
loventral cells per 1,000 mm2 in the deep layer of the
DCN decreased 42% from 81 6 21.0 in normal hearing
animal to 47 6 19.0 in animals 14 days after deafening
(Fig. 5). The tuberculoventral cells (normal, n ¼ 112;
Fig. 4. Changes in cell size in the cochlear nucleus (CN) of normal
hearing rats (white bars) vs. that in rats 14 days after deafness (black
bars). Significant (*P  0.05) decreases are seen in glycine-immunor-
eactive type I stellate multipolar cells, spherical bushy cells and globu-
lar bushy cells, but not radiate cells (type II stellate multipolar cells)
or fusiform cells. Error bars represent 61 standard deviation. AVCN,
anteroventral CN; PVCN, posteroventral CN; VCN, ventral CN;
DCN, dorsal CN.
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deaf, n ¼ 62) also decreased significantly (P  0.01) in
size from an average area of 154.0 6 70.1 mm2 in nor-
mal hearing animals to 108.6 6 47.1 mm2 in animals
14 days after deafness (Fig. 5).
DISCUSSION
The results of this study show marked changes in
the number of glycine-immunoreactive puncta on spheri-
cal bushy, globular bushy, radiate, and fusiform cells
14 days after bilateral deafening. This result is consistent
with a loss of inhibition in the CN after deafness and
decreases in glycine with age-related hearing loss (Willott
et al., 1993; Willott and Turner, 2000) and cochlear abla-
tion (Suneja et al., 1998a,b; Potashner et al., 2000). The
latter studies (Suneja et al., 1998a,b; Potashner et al.,
2000) reported decreases in glycine release after cochlear
ablation in the AVCN and DCN but not the PVCN.
Our results showed decreases in glycine-immunola-
beled puncta on neurons in all three divisions. This may
correlate with decreases in the level of glycine within ter-
minals (bringing it below the level of detection), with a
physical loss of glycine-containing terminals making
somatic contact, or some combination of the two. Ultra-
structural studies (Bilak et al., 1997; Bendiske and Morest,
2004; Kim et al., 2004a,b,c; Subramani and Morest,
2004) and studies using synaptophysin to label terminals
(Muly et al., 2002) demonstrate that there can be marked
changes in terminals and synapses in the CN after deafen-
ing from noise overstimulation. Moreover, decreases in
glycine levels, if they do occur, may not always correlate
with decreases in release and the specific mechanisms that
regulate release. Indeed deafness-related changes in
potential regulators of transmitter release have been dem-
onstrated recently in the auditory brainstem (Suneja and
Potashner, 2003; Zhang et al., 2003). Immunocytochemi-
cal studies at the ultrastructural level after cochlear abla-
tion would therefore be valuable.
There were many glycine-immunoreactive puncta
in the neuropil, in addition to those apposing neuronal
somata that were assessed in the current study. The
immunolabeled puncta in neuropil likely correspond to
axodendritic terminals containing glycine. Because we
could not easily attribute these puncta to a specific neuro-
nal type, we did not assess their number or determine if
that changed after deafening. Qualitatively, however,
there did seem to be a decrease in their number and the
intensity of their immunostaining, suggesting that they
may change as well, in a similar fashion to those on the
neuronal somata.
CN neurons receive glycinergic input from multi-
ple sources, including the DCN (Wickesberg et al.,
1991, 1994; Zhang and Oertel, 1993), the contralateral
VCN (Wenthold, 1987; Babalian et al., 2002), and the
superior olivary complex (e.g., Ostapoff et al., 1997). It
is interesting to consider whether the decrease in glycine
immunostained puncta on CN neurons reflects the loss
of an input from a single source or a decrease across
multiple inputs. The decrease in glycine-immunostained
tuberculoventral cells suggests that they may contribute
to the loss of glycine-immunostained puncta in the
VCN. It will be valuable in future studies to combine
tract tracing and immunocytochemistry to identify fur-
ther the glycine inputs that are most affected.
Spherical bushy, globular bushy, glycine-immunor-
eactive type I stellate multipolar and tuberculoventral cells
all showed decreases in size after deafening, consistent
with previous studies from our lab and others (Lesperance
et al., 1995; Pasic et al., 1994; Pasic and Rubel 1991).
The lack of a cell size change for fusiform cells may be
related to their excitatory input from granule cells of the
shell region, which may be less affected by the deafening.
Another interesting question to consider is why radiate
cells did not show a cell size decrease and suggests they
might also have an alternate source of excitatory input.
With the results of Potashner et al. (2000) and
Suneja et al. (1998a,b) showing decreases in strychnine
binding in the AVCN and PVCN after cochlear abla-
tion, it would be interesting in future studies to compare
and contrast changes in glycine with changes in glycine
receptors as well as comparing and contrasting changes
in GABA and GABA receptors.
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